# Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin

> **NCT05467033** · PHASE3 · RECRUITING · sponsor: **Medical University of Bialystok** · enrollment: 424 (estimated)

## Conditions studied

- Kidney Biopsy

## Interventions

- **DRUG:** Desmopressin
- **DRUG:** intravenous infusion NaCl

## Key facts

- **NCT ID:** NCT05467033
- **Lead sponsor:** Medical University of Bialystok
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-01
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 424 (ESTIMATED)
- **Last updated:** 2025-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05467033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05467033, "Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05467033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*